Related Experiment Videos
Uneven hepatic copper distribution in Wilson's disease
1Dipartimento di Citomorfologia-Sezione Anatomia Patologica, University of Cagliari, Italy.
Journal of Hepatology
|March 1, 1995
Summary
Hepatic copper concentration varies significantly in Wilson's disease patients with cirrhosis. This patchy distribution impacts diagnosis and monitoring of copper-chelating therapy effectiveness.
Area of Science:
- Hepatology
- Medical Diagnostics
- Trace Element Metabolism
Background:
- Hepatic copper concentration is crucial for diagnosing Wilson's disease.
- Wilson's disease involves copper accumulation in the liver.
- Cirrhosis is a late-stage manifestation of Wilson's disease.
Observation:
- A patient with Wilson's disease and cirrhosis exhibited highly variable copper concentrations across 38 liver samples.
- Copper levels ranged from 880 to 2100 µg/g dry weight, with significant differences even in adjacent samples.
- The right liver lobe showed a tendency for higher copper accumulation compared to the left lobe.
Findings:
- Copper distribution in the cirrhotic liver is uneven, with lobar differences and acinar-level heterogeneity.
- Copper predominantly localized to periportal hepatocytes (zone 1) and the periphery of regenerating nodules.
- Some nodules displayed high copper content, while adjacent areas were copper-negative.
Implications:
- Single liver samples may not accurately represent mean hepatic copper concentration in Wilson's disease.
- Sampling variability must be considered in Wilson's disease diagnosis and treatment monitoring.
- Hepatic copper concentration may be an unreliable indicator for monitoring copper-chelating therapy efficacy in cirrhotic stages due to patchy distribution.